EFFECTS OF PASSIVE TILT AND SUBMAXIMAL EXERCISE ON SPECTRAL HEART-RATE-VARIABILITY IN VENTRICULAR-FIBRILLATION PATIENTS WITHOUT SIGNIFICANT STRUCTURAL HEART-DISEASE

it has been shown that tilt and exercise elicit significant changes in autonomic activity in normal subjects and that submaximal exercise causes a greater reduction in heart rate variability (HRV) in animals susceptible to ventricular fibrillation (VF). Whether there is an abnormal HRV response to tilt and exercise in patients at risk of sudden cardiac death (SCD) remains unknown. Short-term HRV before and during passive tilt and exercise was studied in 12 survivors of out-of-hospital cardiac arrest with documented VF and compared with 12 age- and sex-matched normal controls. No patient had significant structural heart disease or left ventricular dysfunction. HRV was computed as total-frequency (TF, 0.01 to 1.00 Hz), low-frequency (LF, 0.04 to 0.15 Hr) and high-frequency (HF, 0.15 to 0.40 Hz) components. There was no significant difference between normal controls and SCD survivors in HRV before or during tilt or submaximal exercise testing. The HF component was significantly decreased during tilt compared with that in the supine position in both normal controls (5.85 +/- 0.61 vs 5.08 +/- 0.95 In(msec(2)), p = 0.005) and patients (5.58 +/- 1.49 versus 4.74 +/- 1.18 In(msec(2)), p = 0.003). There was again no significant change in the TF or LF components during tilt in either patients or controls. All frequency components were significantly decreased during submaximal exercise testing in both patients and controls. However, there was no significant difference in any of these tilt- end exercise-induced changes in HRV between normal controls and SCD survivors. In conclusion, passive head-up tilt and submaximal exercise induce a significant alteration of spectral HRV in survivors of SCD without significant structural heart disease similar to that in normal subjects. Short-term assessment of HRV before and during tilt and submaximal exercise does not help in identifying patients at high risk of SCD in this patient population.